COPD News

Asthma, history of smoking and chronic sinusitis are risk factors for early COPD in U.S. Hispanic/Latino individuals aged younger than 50 years, researchers reported in Annals of the American Thoracic Society.

Astegolimab improved health status but did not significantly reduce exacerbation rates over 48 weeks of treatment compared with placebo in patients with moderate to very severe COPD, according to results from the COPD-ST2OP trial.

The Healio Editors compiled the most-read news in pulmonology posted in March.

Patients with COPD who initiated of single-inhaler triple therapy had improved inhaler adherence and persistence compared with multiple-inhaler triple therapy users, according to a real-world study.

Patients with confirmed COPD had an increased risk for depression and were more likely to receive a prescription for antidepressant medication than individuals without COPD, according to data published in Respiratory Medicine.

Ten-year follow-up data from the COPDGene study show that changes in lung function, respiratory symptom burden and functional capacity in current and former smokers appear to be slow.

Home dust allergen exposures are common in patients with COPD and exposure is associated with adverse outcomes in those who also have allergen sensitization, researchers reported in American Journal of Respiratory and Critical Care Medicine.

Glucocorticoids can do a lot of harm over time. In this episode, John Stone, MD, MPH, walks us through the Glucocorticoid Toxicity Index, a validated tool to measure steroid toxicity over time that we’ll be seeing more of in the future.

The FDA announced approval of the first generic of Symbicort — budesonide and formoterol fumarate dihydrate — Inhalation Aerosol for the treatment of asthma and COPD, according to an agency press release.

Patients with idiopathic pulmonary fibrosis have similar magnitudes of response and completion rates for pulmonary rehabilitation compared with patients with COPD, according to a real-world study published in Chest.